Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cdde41b5-0245-4c47-85f4-5286a17ef4da&Preview=1
Date 8/15/2011
Company Name Pulmatrix
Mailing Address 99 Hayden Avenue Lexington, MA 02421
Company Description Pulmatrix Inc. is a pharmaceutical company developing inhalable aerosols and enabling technologies that help control respiratory infectious disease and human-source airborne contamination.
Proceeds Purposes Proceeds from the financing will enable Pulmatrix to accelerate its lead iCALM drug candidate, PUR118, through Phase 2A efficacy studies in two diseases, chronic obstructed pulmonary disease (COPD) and cystic fibrosis (CF).